Further, knockdown of ZFX has been reported to inhibit cellular proliferation in human laryngeal squamous cell carcinoma, gastric cancer, malignant glioma, non-small cell lung carcinoma and prostate cancer [28-32]. This evidence concerns the gene ZFX and gastric cancer.